123 related articles for article (PubMed ID: 26481547)
1. Stability of erythrocyte membrane and overall hemostasis potential - A biocompatibility study of mebrofenin and other iminodiacetic acid derivatives.
Markowicz-Piasecka M; Mikiciuk-Olasik E; Sikora J
Pharmacol Rep; 2015 Dec; 67(6):1230-9. PubMed ID: 26481547
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biocompatibility Studies of New Iminodiacetic Acid Derivatives.
Markowicz-Piasecka M; Dębski P; Mikiciuk-Olasik E; Sikora J
Molecules; 2017 Dec; 22(12):. PubMed ID: 29258275
[TBL] [Abstract][Full Text] [Related]
3. Extract of Aronia melanocarpa-modified hemostasis: in vitro studies.
Sikora J; Markowicz-Piasecka M; Broncel M; Mikiciuk-Olasik E
Eur J Nutr; 2014 Oct; 53(7):1493-502. PubMed ID: 24452534
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility Studies of Gadolinium Complexes with Iminodiacetic Acid Derivatives.
Markowicz-Piasecka M; Skupień A; Mikiciuk-Olasik E; Sikora J
Biol Trace Elem Res; 2019 Jun; 189(2):426-436. PubMed ID: 30215189
[TBL] [Abstract][Full Text] [Related]
5. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
[TBL] [Abstract][Full Text] [Related]
6. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Kostka B; Para J; Sikora J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
[TBL] [Abstract][Full Text] [Related]
7. New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membrane.
Markowicz-Piasecka M; Sikora J; Mateusiak Ł; Mikiciuk-Olasik E; Huttunen KM
Eur J Pharmacol; 2017 Sep; 811():208-221. PubMed ID: 28606852
[TBL] [Abstract][Full Text] [Related]
8. Studies towards biocompatibility of PAMAM dendrimers--overall hemostasis potential and integrity of the human aortic endothelial barrier.
Markowicz-Piasecka M; Łuczak E; Chałubiński M; Broncel M; Mikiciuk-Olasik E; Sikora J
Int J Pharm; 2014 Oct; 473(1-2):158-69. PubMed ID: 24998508
[TBL] [Abstract][Full Text] [Related]
9. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
[TBL] [Abstract][Full Text] [Related]
10. A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis.
van Geffen M; Loof A; Lap P; Boezeman J; Laros-van Gorkom BA; Brons P; Verbruggen B; van Kraaij M; van Heerde WL
Hematology; 2011 Nov; 16(6):327-36. PubMed ID: 22183066
[TBL] [Abstract][Full Text] [Related]
11. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.
Xin KZ; Chang WC; Ovanesov MV
Thromb Res; 2016 Apr; 140():132-139. PubMed ID: 26632515
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of plasma coagulation and lysis I: Basic kinetic model for time course of coagulation-lysis systems and its potential application to clinical studies.
Garrett ER; Daver J; Desnoyers P; Kosser M; Vincent M
J Pharm Sci; 1978 Feb; 67(2):145-51. PubMed ID: 621627
[TBL] [Abstract][Full Text] [Related]
13. A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.
Amiral J; Laroche M; Seghatchian J
Transfus Apher Sci; 2018 Feb; 57(1):118-126. PubMed ID: 29525568
[TBL] [Abstract][Full Text] [Related]
14. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
15. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
17. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
Klein P; Roth FJ; Rieger H; Popov-Cenic S
Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
[TBL] [Abstract][Full Text] [Related]
18. Epicatechin influences primary hemostasis, coagulation and fibrinolysis.
Sinegre T; Teissandier D; Milenkovic D; Morand C; Lebreton A
Food Funct; 2019 Nov; 10(11):7291-7298. PubMed ID: 31621731
[TBL] [Abstract][Full Text] [Related]
19. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
Nielsen VG
J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
[TBL] [Abstract][Full Text] [Related]
20. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
